Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Kairos Pharma, Ltd. (KAPA) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-1.39M |
|
-- |
|
-- |
|
$1.42M |
|
$-1.42M |
|
$0.03M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.42M |
|
$-1.18M |
|
21.42M |
|
21.42M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$3.17M |
|
-- |
|
$1.28M |
|
$4.46M |
|
$0.27M |
|
-- |
|
-- |
|
$0.27M |
|
$4.19M |
|
$4.19M |
|
$4.19M |
|
21.42M |
|
| Cash Flow Statement Financials | |
$-2.05M |
|
-- |
|
$0.18M |
|
$4.49M |
|
$2.63M |
|
$-1.86M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.98 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.12% |
|
-33.12% |
|
-31.15% |
|
-33.12% |
|
$0.20 |
|
$-0.10 |
|
$-0.10 |
|